3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Dermatologic
1
Classical hematology
1
Conditions
Neoplasms
1
Febrile Neutropenia
1
Interventions
Cyclophosphamide
17
fludarabine phosphate
14
Whole-Body Irradiation
11
Mycophenolic Acid
9
Epoetin Alfa
9
Cyclosporine
9
Busulfan
9
fludarabine
8
Cord Blood Stem Cell Transplantation
8
Antilymphocyte Serum
8
Filgrastim
6
Tacrolimus
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
Methotrexate
5
Darbepoetin alfa
5
Dalteparin
5
Cytarabine
5
eltrombopag
4
Tinzaparin
4
Thiotepa
4
Platelet Transfusion
4
Melphalan
4
Etoposide
4
Arsenic Trioxide
4
thymoglobulin
3
epoetin beta
3
Vorinostat
3
Transplantation
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Amoxicillin-Potassium Clavulanate Combination
×
Classical hematology
×
Clear all
NCT03003273
2019-02-01
DALFEN
All India Institute of Medical Sciences
Phase 3
Terminated
142 enrolled